Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 101 (3), 398-402
- https://doi.org/10.1016/j.ygyno.2005.10.035
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancerGynecologic Oncology, 2005
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- First-Line Chemotherapy with Paclitaxel and Platinum for Advanced and Recurrent Cancer of the Cervix—A Phase II StudyGynecologic Oncology, 1999
- The Prognostic Factors for Patients with Early Cervical Cancer Treated by Radical Hysterectomy and Postoperative RadiotherapyGynecologic Oncology, 1999
- A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- In VitroPhase II Comparison of the Cytotoxicity of a Novel Platinum Analog, Nedaplatin (254-S), with That of Cisplatin and Carboplatin against Fresh, Human Cervical CancersGynecologic Oncology, 1998
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997
- A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: A Southwest Oncology Group StudyGynecologic Oncology, 1990
- Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1990
- Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancerGynecologic Oncology, 1990